The global healthcare sector is predicted to undergo a major transformation through the adoption of generative artificial intelligence (AI). According to a recent report, the market value of this technology, recorded at USD 1.84 billion in 2024, is projected to skyrocket to USD 21.64 billion by 2034, registering a compound annual growth rate (CAGR) of 31.4%.
This massive growth is driven by the integration of AI solutions across critical aspects, ranging from medical imaging and diagnostic processes to the acceleration of drug discovery. In addition, the use of AI in administrative automation is key to mitigating medical staff burnout while improving clinical outcomes for patients.
North America currently holds control of the market, supported by advanced technological infrastructure and high investment allocations in digital health. Technically, cloud-based models and large language models serve as the main foundation dominating the future development of this technology.
Despite the highly promising market potential, the sector still faces significant hurdles. Key challenges that must be addressed include strict regulations, sensitive patient data privacy issues, and integration barriers with legacy hospital systems that have not been updated. On the other hand, the emergence of domain-specific AI models presents a major opportunity for new players to enter this growing market.
